Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles
Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles
Emilie Réboursière,H. Fouques,9 Authors,S. Cheze
2016 · DOI: 10.1007/s12185-016-1992-4
International journal of hematology · 18 Citations
TLDR
Rituximab should be considered as an alternative treatment to splenectomy for chronic immune thrombocytopenia patients, and its efficacy and safety profile should lead to choose this medical option therapy before surgery for ITP patients.